SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-047672
Filing Date
2019-10-08
Accepted
2019-10-08 16:18:47
Documents
18
Period of Report
2019-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv530777_8k.htm   iXBRL 8-K 36343
2 EXHIBIT 4.1 tv530777_ex4-1.htm EX-4 114792
3 EXHIBIT 5.1 tv530777_ex5-1.htm EX-5.1 9184
4 EXHIBIT 10.1 tv530777_ex10-1.htm EX-10.1 212464
5 EXHIBIT 99.1 tv530777_ex99-1.htm EX-99.1 12830
9 GRAPHIC image_001.jpg GRAPHIC 10777
10 GRAPHIC tv530777_ex99-1img01.jpg GRAPHIC 21829
  Complete submission text file 0001144204-19-047672.txt   693839

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA srne-20191007.xsd EX-101.SCH 3222
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20191007_lab.xml EX-101.LAB 34591
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20191007_pre.xml EX-101.PRE 22734
16 EXTRACTED XBRL INSTANCE DOCUMENT tv530777_8k_htm.xml XML 3490
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 191142876
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services